Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pestic Biochem Physiol ; 105(1): 57-61, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24238291

RESUMO

Disorder of glucose homeostasis is one of the most important complications following exposure to organophosphorous (OPs) pesticides. Regarding the importance of adipose tissue in regulating blood glucose and the role of oxidative stress in toxicity of OPs and in the continue of our previous works, in the present study we focused on tumor necrosis factor alpha (TNFα), glucose transporter type 4 (GLUT4), and nuclear factor kappa-light-chain-enhancer of activated B cells (Nf-κB) in a sublethal model of toxicity by diazinon as a common OPs. Following time-course study of various doses of diazinon in impairing blood glucose, dose of 70mg/kg/day was found the optimum. Animals were treated for 4 weeks and after gavage of glucose (2g/kg), the glucose change was evaluated at time-points of 0, 30, 60, 120 and 180min to identify oral glucose tolerance test (GTT). In addition, serum insulin was measured in fasting condition. In adipose tissue, oxidative stress markers including reactive oxygen species (ROS), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and TNFα were evaluated. The mRNA expression of GLUT4, Nf-κB and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were also determined by real time reverse transcription polymerase chain reaction (RT-PCR). Diazinon at dose of 70mg/kg/day impaired GTT and diminished insulin level while augmented ROS, NADPH oxidase, and TNFα. The GLUT4 mRNA expression was amplified by diazinon while unlikely, the expression of Nf-κB gene did not change. On the basis of biochemical and molecular findings, it is concluded that diazinon impairs glucose homeostasis through oxidative stress and related proinflammatory markers in a way to result in a reduced function of insulin inside adipose tissue. Although, diazinon interfered with pancreatic influence on the adipose tissue most probably via stimulation of muscarinic receptors, current data are not sufficient to introduce adipose tissue as a target organ to OPs toxicity. Considering the potential of OPs to accumulate in adipose tissue, it seems a good candidate organ for future studies. Although, hyperglycemia was not induced by diazinon but increased AUC0-180min leads us to the point that diazinon induces kind of instability in glucose homostasis and diabetes.


Assuntos
Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/metabolismo , Diabetes Mellitus Tipo 2/induzido quimicamente , Diazinon/toxicidade , Glucose/metabolismo , Inseticidas/toxicidade , Estresse Oxidativo/efeitos dos fármacos , Animais , Diabetes Mellitus Tipo 2/genética , Diabetes Mellitus Tipo 2/metabolismo , Diazinon/metabolismo , Exposição Ambiental , Transportador de Glucose Tipo 4/genética , Transportador de Glucose Tipo 4/metabolismo , Humanos , Inseticidas/metabolismo , Masculino , NF-kappa B/genética , NF-kappa B/metabolismo , Ratos , Ratos Wistar
2.
Toxicol Mech Methods ; 23(2): 120-6, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22978792

RESUMO

CONTEXT: Cancer is a disease characterized by abnormal growth of cells. One of the most common types of liver cancers is called hepatocellular carcinoma (HCC) which is highly metastatic. As most of cannabinoids have shown anticancer effect against different cell lines in a number of reports, a biological investigation of two cannabinoids, CB65 (CB2 receptor agonist) and ACEA (CB1 receptor agonist) was carried out in this study. OBJECTIVE: In an attempt to find natural products as a new solution of cancer, this study was designed to investigate the potential antitumoral and anti-invasive activity of cannabinoids on HepG2 cells and the possible roles of matrix metalloproteinase-2 (MMP-2) and MMP-9 in its action. MATERIALS AND METHODS: The researchers examined the effect of various concentrations of CB65 (CB2 receptor agonist) and ACEA (CB1 receptor agonist), on the cell proliferation, viability, and invasion as well as expression of MMP-2 and MMP-9 in HepG2 cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assay, matrigel invasion assay, and western blotting method. RESULTS: The results revealed that both cannabinoids reduce cell viability, cell invasion as well as MMP-2 and MMP-9 expression in higher dose of 20 nM. Furthermore, higher concentrations of examined cannabinoids were more effective. DISCUSSION: These data suggest ACEA and CB65 as an option for novel treatment of hepatocellular cancer. CONCLUSION: Our findings may contribute to design of new therapeutic strategies for the management of HCC.


Assuntos
Antineoplásicos/farmacologia , Ácidos Araquidônicos/farmacologia , Canabinoides/farmacologia , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Carcinoma Hepatocelular/enzimologia , Carcinoma Hepatocelular/secundário , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Células Hep G2 , Humanos , Neoplasias Hepáticas/enzimologia , Neoplasias Hepáticas/patologia , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Invasividade Neoplásica , Receptor CB1 de Canabinoide/agonistas , Receptor CB1 de Canabinoide/metabolismo , Receptor CB2 de Canabinoide/agonistas , Receptor CB2 de Canabinoide/metabolismo
3.
Toxicol Mech Methods ; 22(6): 476-82, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22409398

RESUMO

Insulin Dependent Diabetes Mellitus (IDDM) is a disease with high incidence with no pure cure therapy yet. In most of cases, these patients need pancreatic islets transplantation that is not completely successful because of oxidative stress happening during isolation and transplantation procedures. In the present study, effective factors in transplantation procedure such as viability, insulin secretion, production of reactive oxygen molecules (ROM), and mitochondrial energy as ATP/ADP ratio were examined in the isolated islets exposed to sodium selenite (Na2SeO3; 0 30 nmol/L), metal form of cerium oxide (100 nm), cerium oxide nanoparticles (100 nm) and combination of Na2SeO3 (30 nmol/L)/cerium oxide nanoparticles (100 nm) in a time course (1, 2, 4 and 6 days posttreatment) manner. The results showed a significant increase of cells viability, secretion of insulin, and ATP/ADP ratio and a reduction in ROM by use of sodium selenite, cerium oxide nanoparticles, and especially combination of cerium oxide nanoparticles/sodium selenite. Interestingly, not only no improvement was found with metal form of cerium oxide but also deterioration occurred in tested markers. Results suggest that pretreatment with combination of cerium oxide nanoparticles/sodium selenite can improve transplantation outcome and graft function by control of oxidative stress damage.


Assuntos
Cério/farmacologia , Ilhotas Pancreáticas/efeitos dos fármacos , Nanopartículas , Estresse Oxidativo , Selenito de Sódio/farmacologia , Difosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Metabolismo Energético , Técnicas In Vitro , Insulina/metabolismo , Secreção de Insulina , Ilhotas Pancreáticas/metabolismo , Ilhotas Pancreáticas/fisiologia , Masculino , Ratos , Ratos Wistar
4.
World J Diabetes ; 2(11): 204-10, 2011 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-22087357

RESUMO

AIM: To study the combinative effects of nanocerium and selenium in a murine model of diabetes. METHODS: Cerium oxide (CeO(2)) nanoparticles (60 mg/kg per day) and sodium selenite (5 µmol/kg per day) alone or in combination, or the metal form of CeO(2) (60 mg/kg) were administered for 2 wk by intraperitoneal injection to streptozotocin-induced diabetic rats. At the end of treatment blood was collected, liver tissue dissected and then oxidative stress markers, extent of energy depletion and lipid profile were evaluated. RESULTS: Antioxidant enzymes and high density lipoprotein decreased whereas oxidative stress, adenosine diphosphate/adenosine triphospahte levels, cholesterol, triglyceride and low density lipoprotein increased on induction of diabetes. All were improved by a combination of nanocerium and sodium selenite. There was a relative amelioration by CeO(2) nanoparticles or sodium selenite alone, but the metal form of CeO(2) showed no significant improvement. CONCLUSION: The combination of nanocerium and sodium selenite is more effective than either alone in improving diabetes-induced oxidative stress.

5.
Basic Clin Pharmacol Toxicol ; 109(5): 381-6, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21668649

RESUMO

Diabetic neuropathy (DN) is the most common peripheral neuropathy and long-term complication of diabetes. In view of the pathological basis for the treatment of DN, it is important to prevent nerve degeneration. Most of the current treatment strategies are symptomatic therapies. In this study, we evaluated the effectiveness of magnesium-25, carrying porphyrin-fullerene nanoparticles, on diabetes-induced neuropathy. Previous studies have suggested that dorsal root ganglion (DRG) neurons comprise a specific target and may be responsible for the known complications of DN. Experimental DN was induced by intraperitoneal injection of streptozotocin (STZ) (45 mg/kg). Different forms of magnesium including (25)Mg-PMC16, (24)Mg-PMC16 and MgCl(2) were administered intravenously in equal dose (0.5 LD(50)) at 48-hr intervals before STZ injection. Peripheral nerves were studied after 2 months of diabetes in groups using qualitative approaches, morphometric analysis of DRG neurons and motor function tests. We showed that STZ-induced DN caused morphological abnormalities in DRG neurons comprising changes in area, diameter and number of A and B cells as well as motor dysfunction in DN. Moreover, our findings indicated that administration of (25)Mg-PMC16 as a magnetic form of Mg improved morphological abnormalities and motor dysfunctions significantly, whereas other forms of Mg were ineffective.


Assuntos
Neuropatias Diabéticas/tratamento farmacológico , Neuropatias Diabéticas/patologia , Fulerenos/administração & dosagem , Gânglios Espinais/efeitos dos fármacos , Magnésio/administração & dosagem , Porfirinas/administração & dosagem , Animais , Biomarcadores , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/patologia , Relação Dose-Resposta a Droga , Sistemas de Liberação de Medicamentos , Masculino , Nanopartículas Metálicas/química , Neurônios/patologia , Estresse Oxidativo/efeitos dos fármacos , Nervos Periféricos/efeitos dos fármacos , Nervos Periféricos/patologia , Ratos , Estreptozocina/metabolismo
6.
Arh Hig Rada Toksikol ; 60(2): 157-64, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19581208

RESUMO

Hyperglycaemia has been observed with exposure to organophosphate insecticides. This study was designed to compare the effects of calcium channel blockers, alpha-adrenergic, beta-adrenergic, and muscarinic receptor blockers, and of free radical scavengers on insulin secretion from diazinon-treated islets of Langerhans isolated from the pancreas of rats using standard collagenase digestion, separation by centrifugation, and hand-picking technique. The islets were then cultured in an incubator at 37 degrees C and 5 % CO2. In each experimental set 1 mL of 8 mmol L(-1) glucose plus 125 microg mL(-1) or 625 microg mL(-1) of diazinon were added, except for the control group, which received 8 mmol L(-1) glucose alone. The cultures were then treated with one of the following: 30 micromol L(-1) atropine, 100 micromol L(-1) ACh + 10 micromol L(-1) neostigmine, 0.1 micromol L(-1) propranolol, 2 micromol L(-1) nifedipine, 50 micromol L(-1) phenoxybenzamine, or 10 micromol L(-1) alphatocopherol. In all experiments, diazinon significantly reduced glucose-stimulated insulin secretion at both doses, showing no dose dependency, as the average inhibition for the lower dose was 62.20 % and for the higher dose 64.38 %. Acetylcholine and alpha-tocopherol restored, whereas atropine potentiated diazinon-induced hyposecretion of insulin. Alpha-, beta- and calcium channel blockers did not change diazinon-induced effects. These findings suggest that diazinon affects insulin secretion mainly by disturbing the balance between free radicals and antioxidants in the islets of Langerhans and by inducing toxic stress.


Assuntos
Antagonistas Adrenérgicos/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Sequestradores de Radicais Livres/farmacologia , Inseticidas/farmacologia , Insulina/metabolismo , Ilhotas Pancreáticas/metabolismo , Animais , Inibidores da Colinesterase , Diazinon , Relação Dose-Resposta a Droga , Glucose/farmacologia , Técnicas In Vitro , Secreção de Insulina , Masculino , Antagonistas Muscarínicos/farmacologia , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...